UPC Analytics
ENDE
Overview · Filed: —

ACT_459987/2023

A SYSTEM COMPRISING A PROSTHETIC VALVE AND A DELIVERY CATHETER

InfringementMain Infringement ActionMunich LDInfringement Action—
OverviewDecisionsReasoningCitationsDocumentsTimeline
Parties

Claimants

Reps: Boris Kreye (Bird & Bird LLP); Elsa Tzschoppe (Bird & Bird LLP)

Respondents

Reps: Andreas von Falck (Hogan Lovells); Roman Würtenberger (Hogan Lovells); Lukas Wollenschlaeger (Hogan Lovells)
Judges
  • Matthias ZigannPresiding Judge / Judge-Rapporteur (Munich Local Division)
Patents
  • EP 3 646 825
  • EP 3646825
CPC codes: A61F2220/0075, A61F2/2436, A61F2250/0065, A61F2/2418, A61F2230/0054, A61F2250/0069, A61F2/2433

Technology area: Medical Devices · Implants

Sector: Pharmaceutical & Medical

Outcome
InfringedInfringed
Filed: —
First decided: Sep 6, 2024
Last decision: Nov 15, 2024
Language: —

Munich Local Division full merits decision finding that Meril Life Sciences Pvt Ltd and Meril GmbH infringed Edwards Lifesciences Corporation's patent EP 3 646 825 (a heart valve technology patent). The court ordered a permanent injunction to cease and desist from the infringing acts (transcatheter heart valve products) across all UPC contracting states where the patent has effect, recall of infringing products from commercial channels (excluding devices already scheduled for patient implantation by 15 November 2024), destruction of infringing stock, disclosure of information about distribution and quantities, publication of the decision, and an obligation to pay damages (quantum to be determined separately). The defendant's counterclaim for revocation was dismissed, the patent being upheld as valid. Costs were addressed separately.

Claims
At issueall
Infringedall
Notes: Munich Local Division found infringement of EP 3 646 825 by Meril transcatheter heart valve products; no specific claim numbers enumerated in the operative part of the excerpt.